Skip to content
Options Trading Report

Options Trading Report

Primary Menu
  • Home
  • Business
  • Economy
  • Top News
  • Newsletters
Volkswagen Is Cheap at 0.2x Book. That Does Not Make It a Buy. 0dbe378b-666f-401b-b656-883fa6c36604
  • Top News

Volkswagen Is Cheap at 0.2x Book. That Does Not Make It a Buy.

Editor November 16, 2026
With operating profit forecast near zero in 2026 and a margin target for 2030, VW shows how...
Read More Read more about Volkswagen Is Cheap at 0.2x Book. That Does Not Make It a Buy.
ATTENTION: Elon’s silent partner d10eb737-1317-4d08-92f1-145e241802ee
  • Newsletters

ATTENTION: Elon’s silent partner

Editor November 16, 2026
A note from our friends at Millionaire Publishing(ad) Dear Reader, Most people hear “SpaceX” and think rockets....
Read More Read more about ATTENTION: Elon’s silent partner
Japan Households Are Losing Ground. BOJ May Hike Anyway. f633cd92-8b68-4dff-b074-bf9686859ba4
  • Newsletters

Japan Households Are Losing Ground. BOJ May Hike Anyway.

Editor November 16, 2026
Japan’s Cabinet Office released Q3 GDP figures this morning, and the number arrived with the wrong sign....
Read More Read more about Japan Households Are Losing Ground. BOJ May Hike Anyway.
Wall Street’s Hottest Stock Has a Waiting List. Here’s How to Skip It. e9eede42-4477-4df8-95c2-0f39f3da350a
  • Newsletters

Wall Street’s Hottest Stock Has a Waiting List. Here’s How to Skip It.

Editor November 16, 2026
A note from our friends at The Oxford Club(ad) From the man who tabbed NVIDIA before it...
Read More Read more about Wall Street’s Hottest Stock Has a Waiting List. Here’s How to Skip It.
Summit Therapeutics Paid $500 Million for Ivonescimab. The FDA Just Said No. 3da59921-e115-4295-8a85-48f19ed144d3
  • Top News

Summit Therapeutics Paid $500 Million for Ivonescimab. The FDA Just Said No.

Editor November 16, 2026
The rejection of Summit's lung cancer drug tests every Western thesis on Chinese oncology assets.
Read More Read more about Summit Therapeutics Paid $500 Million for Ivonescimab. The FDA Just Said No.
Ackman Says Big Tech’s $740 Billion Bet Will Pay Off. Apple’s $5.2 Trillion Says Otherwise. 9463ab74-d743-4dd0-ae88-5bd016dbacca
  • Business

Ackman Says Big Tech’s $740 Billion Bet Will Pay Off. Apple’s $5.2 Trillion Says Otherwise.

Editor November 15, 2026
The week’s market verdict rewarded the megacap that spent least on AI and punished the hardware complex...
Read More Read more about Ackman Says Big Tech’s $740 Billion Bet Will Pay Off. Apple’s $5.2 Trillion Says Otherwise.
Home Depot Reports Tuesday. The Housing Bet Is the Story. 232acc7d-e20d-449a-ab4b-77b4b4acc2d1
  • Economy

Home Depot Reports Tuesday. The Housing Bet Is the Story.

Editor November 15, 2026
Frozen housing, a $23.8 billion Pro bet, stock flat all year. Q3 results arrive Tuesday.
Read More Read more about Home Depot Reports Tuesday. The Housing Bet Is the Story.
Cisco Just Posted Its Best Quarter in 15 Years. The Stock Dropped 7%. 034aa88a-7fdd-40fe-ac94-52c4f85649f1
  • Economy

Cisco Just Posted Its Best Quarter in 15 Years. The Stock Dropped 7%.

Editor November 14, 2026
Record revenue, a bigger AI forecast, and a networking supercycle that is barely started. The selloff is...
Read More Read more about Cisco Just Posted Its Best Quarter in 15 Years. The Stock Dropped 7%.
Trump’s Invisible Dollar Reset 34e2b644-e695-45c0-b3b7-c1c91322663f
  • Newsletters

Trump’s Invisible Dollar Reset

Editor November 14, 2026
A note from our friends at Porter & Co(ad) No new bills, no new coins, no crypto,...
Read More Read more about Trump’s Invisible Dollar Reset
Disney Reports Tuesday With $7.54 on the Line 1b02fee4-e2a5-418e-bf37-2a93c2e1e288
  • Newsletters

Disney Reports Tuesday With $7.54 on the Line

Editor November 14, 2026
Markets don’t need a great quarter. They only need one that beats what was already priced in....
Read More Read more about Disney Reports Tuesday With $7.54 on the Line

Posts pagination

1 2 3 4 … 80 Next

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Want More Market News?
Add your email address below to get up to date market news and more!
By submitting your email address, you'll receive a free subscription to Options Trading Report newsletter (Privacy Policy). These newsletters are completely free - and always will be. You will also receive occasional offers about products and services available to you from our affiliates. You can unsubscribe at any time.

Recent Posts

  • Volkswagen Is Cheap at 0.2x Book. That Does Not Make It a Buy.
  • ATTENTION: Elon’s silent partner
  • Japan Households Are Losing Ground. BOJ May Hike Anyway.
  • Wall Street’s Hottest Stock Has a Waiting List. Here’s How to Skip It.
  • Summit Therapeutics Paid $500 Million for Ivonescimab. The FDA Just Said No.
  • Ackman Says Big Tech’s $740 Billion Bet Will Pay Off. Apple’s $5.2 Trillion Says Otherwise.
  • Home Depot Reports Tuesday. The Housing Bet Is the Story.

Search

Categories

  • Business
  • Economy
  • Market News
  • Newsletters
  • Top News

You may have missed

0dbe378b-666f-401b-b656-883fa6c36604
  • Top News

Volkswagen Is Cheap at 0.2x Book. That Does Not Make It a Buy.

Editor November 16, 2026
d10eb737-1317-4d08-92f1-145e241802ee
  • Newsletters

ATTENTION: Elon’s silent partner

Editor November 16, 2026
f633cd92-8b68-4dff-b074-bf9686859ba4
  • Newsletters

Japan Households Are Losing Ground. BOJ May Hike Anyway.

Editor November 16, 2026
e9eede42-4477-4df8-95c2-0f39f3da350a
  • Newsletters

Wall Street’s Hottest Stock Has a Waiting List. Here’s How to Skip It.

Editor November 16, 2026
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms of Service/Use Agreement
  • Contact Us
Copyright 2026 © All rights reserved | Options Trading Report | optionstradingreport.com SITE_OK
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}